Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

NCT06134375

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +10 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • NYU Langone perimutter Cancer Center New York, United States
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NCT06270706

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

NCT06195709

Conditions
Breast Carcinoma, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Centre Hospitalier de la Côte basque Bayonne, France
  • Institut Bergonié Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
  • Centre Francois Baclesse Caen, France
View all 21 locations
View Trial Details
Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

NCT06947928

Conditions
Adenocarcinoma, Advanced Or Metastatic Merkel Cell Carcinoma, Carcinoma, +22 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford Health Care - Skin Cancer Program Stanford, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 18 locations
View Trial Details

Related conditions